JCM
SANA icon

Jacobi Capital Management’s Sana Biotechnology SANA Stock Holding History

Jacobi Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8K Hold
10,000
– – ﹤0.01% 631
2025
Q4 		$40.7K Buy
+10,000
New +$44.8K ﹤0.01% 608
2021
Q4 		– Sell
-100
Closed -$2K – 1139
2021
Q3 		$2K Hold
100
– – ﹤0.01% 1337
2021
Q2 		$2K Hold
100
– – ﹤0.01% 1280
2021
Q1 		$3K Buy
+100
New +$3.26K ﹤0.01% 1214

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Jacobi Capital Management's SANA Position: Q1 2026 in Review

Jacobi Capital Management held its Sana Biotechnology (SANA) position steady in Q1 2026 at 10,000 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Jacobi Capital Management first reported a position in SANA in Q1 2021 and has held it in 5 quarters since. The position peaked at $40.7K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Jacobi Capital Management held 10,000 shares of Sana Biotechnology worth $28.8K as of Q1 2026.
  • Jacobi Capital Management left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Jacobi Capital Management's portfolio in Q1 2026, its #631 holding.
  • Jacobi Capital Management first reported a position in Sana Biotechnology in Q1 2021 and has held it in 5 quarters since.
  • Jacobi Capital Management's Sana Biotechnology position peaked at $40.7K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.